Introducing Case Studies: Five Landmark Deals

Introduction

KKR won RJR Nabisco in a roughly $31 billion buyout, the most famous takeover fight of the 1980s, and almost nobody made money. Elon Musk signed a binding contract to buy Twitter, spent months trying to escape it, and was marched to closing at the original price anyway. Pfizer built a $160 billion merger entirely inside the existing tax rules, and a single Treasury notice unwound it in five months. The distance between what people think they know about a famous deal and what the documents actually show is large, and closing it is the whole reason we built Case Studies.

Case Studies is a new section that takes a landmark transaction and reconstructs it from the public record: how the deal was structured, who advised each side, what the contract actually said, where the leverage sat, and who turned out to be right. It is not a quiz, a summary, or a highlight reel. It is the closest thing to sitting in the room that a written account can be, built for anyone who finds these deals genuinely interesting: finance professionals, founders, students, journalists, and the simply curious. The section launches with five of the most consequential deals of the last forty years, and more will be added on a regular cadence.

The format is deliberate. Most online write-ups of famous deals are either a thousand-word recap or a triumphant narrative with the outcome assumed from the first line. Neither teaches you how the deal actually worked.

Reconstructions, Not Recaps

Each case study walks the transaction in the order it happened, with the information the participants actually had at each point. You see the opening bid before you see the counter, the contract terms before you see how they were tested, the strategic logic before you know whether it paid off. That sequencing matters: a deal only makes sense when you stop treating the outcome as inevitable and start seeing the decisions as they were faced.

Built From the Public Record

The spine of every case study is the primary document. The Musk and Twitter reconstruction is anchored in the actual merger agreement and the SEC filing recording the deal's closing at $54.20 a share, which is why the "he was forced to close" claim is precise rather than rhetorical. The Pfizer and Allergan study leans on the companies' own 8-K announcing the termination after the Treasury rule change. Working from filings rather than headlines is what lets the studies be specific about structure, advisers, fees, and timing.

Who They Are For

The honest answer is a wide audience. If you work in finance, these are the deals your seniors reference in shorthand and assume you know. If you are studying, they are the canonical transactions every curriculum gestures at but rarely unpacks. If you are a founder or operator, they show how control, price, and contracts actually behave under pressure. And yes, if you are preparing for interviews, being able to genuinely discuss one of these is worth more than a dozen rehearsed talking points, but that is one use among many, not the reason the section exists.

Go deeper on the people and stories behind the numbers: Explore short-form finance narratives in our companion app, download the iOS app for deals, founders, and market history on the go.

Disney's $71 Billion Fight for Fox

Disney's acquisition of 21st Century Fox was not a clean purchase; it was a contested process in which Comcast's all-cash counterbid forced Disney to raise its original all-stock offer to roughly $71.3 billion for the assets that would become the backbone of its streaming strategy. Part of the structure is the part most retellings skip: Fox separated out the businesses Disney did not want, the broadcast network, news, and sports, into a standalone company, so the deal was a carve-out as much as an acquisition. The case study traces the strategic logic (why Disney wanted the studio, the content library, and the international distribution), the bidding dynamics against Comcast, the regulatory path, and the structure that let Disney win without overpaying for the parts it did not want. It connects directly to how strategic and sponsor buyers think differently about price.

Elon Musk's $44 Billion Twitter Deal

The Musk and Twitter story is the clearest modern lesson in why deal contracts exist. Musk agreed to buy Twitter for $54.20 a share, roughly $44 billion, then tried to terminate, and the merger agreement's remedy provisions left him with almost no exit. The case study walks the offer, the financing, the attempted termination, the Delaware litigation, and the closing at the original price.

Specific Performance

A legal remedy that forces a party to actually complete a contract rather than simply pay damages for breaking it. In M&A, a specific-performance clause lets the seller compel a reluctant buyer to close the deal as agreed. It is the provision that effectively ended Elon Musk's attempt to walk away from the Twitter acquisition, because the contract entitled Twitter to make him close rather than just sue for money.

KKR's $31 Billion RJR Nabisco Buyout

The RJR Nabisco buyout is the defining leveraged buyout of the 1980s and still the cleanest illustration of how an LBO auction, management conflicts, and board duty collide. KKR won a roughly $31 billion deal (including assumed debt) against a management-led group, and the board's special committee chose KKR even though the management bid looked higher on headline per-share value, judging KKR's overall package and securities more credible and its commitments to employees and structure more acceptable. The returns then disappointed almost everyone, which is the part that makes it a lasting lesson rather than a victory lap. The mechanics here connect to the modern take-private LBO process.

Leveraged Buyout (LBO)

The acquisition of a company financed largely with borrowed money, where the target's own cash flows and assets service and repay the debt. The buyer (typically a private equity firm) contributes a minority of the purchase price as equity and relies on debt paydown, operational improvement, and eventual sale to generate returns. RJR Nabisco was the era-defining example of how aggressive an LBO auction could become.

Pfizer's $160 Billion Allergan Inversion

The Pfizer and Allergan study is a lesson in deal risk that has nothing to do with price. The roughly $160 billion combination was structured as a reverse-merger inversion that was entirely legal when signed; a US Treasury rule change in April 2016 reclassified its economics, and the parties terminated within days, with Pfizer reimbursing Allergan about $150 million of expenses. It is the canonical case for why regulatory and tax-law risk belongs in every deal discussion.

Corporate Inversion

A transaction in which a company reincorporates abroad, usually by merging with a smaller foreign company, to move its tax domicile to a lower-tax jurisdiction while keeping its operations largely unchanged. Inversions were a major M&A driver in the 2010s until US Treasury rule changes sharply curtailed their tax benefits. The Pfizer-Allergan deal was the largest attempted inversion and was abandoned when those rules changed.

Facebook's $16 Billion IPO

The Facebook 2012 IPO was declared a failure in real time and looks very different with distance. Priced at $38 for a roughly $16 billion raise, with the size and price pushed up into apparent demand, it opened into a Nasdaq order-system failure that left traders unsure for hours whether their orders had executed. The lead underwriters then used the over-allotment and stabilization mechanics to defend the $38 level on the first day, the stock still fell by roughly half over the following months, and the original valuation was eventually vindicated anyway. The study covers pricing, the greenshoe and stabilization mechanics, the trading-systems breakdown, and the long arc of who was actually right, and pairs naturally with how the IPO process works.

Get the complete technical and behavioral framework: Download our comprehensive 160-page PDF, access the IB Interview Guide covering the deal mechanics these case studies bring to life.

Read a few of these and the same lessons surface across very different transactions: price is rarely the only thing the seller is optimizing, the contract is where leverage actually lives, regulatory and financing risk decide more deals than valuation does, and the "obvious" outcome was almost never obvious at the time. Those are not interview tricks; they are how transactions behave, and they transfer to any deal you ever read about or work on. If you also happen to be preparing for interviews, a single deal you genuinely understand end to end will carry you further than a stack of memorized summaries, which is why these pair well with the private equity case study framework.

Five is the launch set, not the ceiling. The section will grow on a regular cadence, spanning more eras, more deal types (hostile defenses, restructurings, failed deals, founder-led buyouts), and more of the transactions that shaped how finance is practiced. The selection favors deals where the public record is rich enough to reconstruct honestly and where the lesson outlives the headline. If you want the people-and-narrative companion to these structural breakdowns, the Finance Stories collection covers the characters; Case Studies covers the mechanics.

The reason landmark deals are worth this level of attention is that they are the reference points the entire industry argues from. People invoke RJR Nabisco, the Twitter saga, or the Pfizer inversion as one-line shorthand, and most of the time the shorthand is wrong or hollow. Case Studies exists to replace the shorthand with the actual sequence of decisions, constraints, and documents, so that when you reference one of these deals you are standing on the record rather than the legend.

Start with whichever case study sounds most interesting, read the linked filings alongside it, and let the deal unfold in the order the participants lived it. That is the point of the section: not to tell you what happened, but to let you see how it happened, and decide for yourself who was right.